Abbott Laboratories (ABT)
116.67
+0.03
(+0.03%)
USD |
NYSE |
Aug 24, 16:00
116.62
-0.05
(-0.04%)
After-Hours: 20:00
Abbott Laboratories Total Liabilities (Quarterly) : 57.45B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.45B |
| March 31, 2026 | 57.73B |
| December 31, 2025 | 33.94B |
| September 30, 2025 | 32.92B |
| June 30, 2025 | 33.17B |
| March 31, 2025 | 32.38B |
| December 31, 2024 | 33.51B |
| September 30, 2024 | 34.33B |
| June 30, 2024 | 33.46B |
| March 31, 2024 | 33.42B |
| December 31, 2023 | 34.39B |
| September 30, 2023 | 34.40B |
| June 30, 2023 | 35.95B |
| March 31, 2023 | 36.56B |
| December 31, 2022 | 37.53B |
| September 30, 2022 | 36.92B |
| June 30, 2022 | 37.49B |
| March 31, 2022 | 38.38B |
| December 31, 2021 | 39.17B |
| September 30, 2021 | 39.16B |
| June 30, 2021 | 39.24B |
| March 31, 2021 | 39.00B |
| December 31, 2020 | 39.54B |
| September 30, 2020 | 37.45B |
| June 30, 2020 | 37.98B |
| Date | Value |
|---|---|
| March 31, 2020 | 36.35B |
| December 31, 2019 | 36.59B |
| September 30, 2019 | 36.52B |
| June 30, 2019 | 36.53B |
| March 31, 2019 | 36.48B |
| December 31, 2018 | 36.45B |
| September 30, 2018 | 40.74B |
| June 30, 2018 | 37.64B |
| March 31, 2018 | 39.31B |
| December 31, 2017 | 45.15B |
| September 30, 2017 | 40.03B |
| June 30, 2017 | 39.36B |
| March 31, 2017 | 39.34B |
| December 31, 2016 | 34.29B |
| September 30, 2016 | 18.60B |
| June 30, 2016 | 19.04B |
| March 31, 2016 | 18.80B |
| December 31, 2015 | 22.68B |
| September 30, 2015 | 20.51B |
| June 30, 2015 | 21.00B |
| March 31, 2015 | 21.11B |
| December 31, 2014 | 22.15B |
| September 30, 2014 | 19.52B |
| June 30, 2014 | 17.77B |
| March 31, 2014 | 18.17B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 26.31B |
| Boston Scientific Corp. | 20.04B |
| DexCom, Inc. | 3.834B |
| Insulet Corp. | 1.743B |
| Intuitive Surgical, Inc. | 2.579B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.22B |
| Shareholders Equity (Quarterly) | 51.11B |
| Debt to Equity Ratio | 0.638 |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | -2.47% |